US 8293800
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
granted A61KA61K31/122A61P
Quick answer
US patent 8293800 (Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/122, A61P, A61P25/00, A61P37/00